5th International Conference

ON

Cancer and Oncology

Event Date

March 25-26, 2024

Venue

London, UK

@ Marriott Hotel London Heathrow Airport

– QUICK LINKS –

– Previous Conference Performers / Professionals From Around The Globe

Aikaterini Ziaka

Physio4you, Greece

Elizabeth Mahon

Liverpool John Moores University, United Kingdom

Farah naaz Kazi

United Kingdom

Huang Wei Ling, MD,

Brazil

Iskandar r Budianto 

Atma jaya University. Jakarta

Michael Fossel

Michigan State University , USA

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia

Jorge Arturo Hernandez 

Mexico

Nkechi M Enwerem, 

Harvard University,USA

Said El deib

YAS Clinic , UAE

Sandra Velez-Candelario

Family Organizational Psychology LLC, USA

Xu chen

USA

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

About CANCER CONFERENCE 2024

ConferenceMinds thrilled to announce the 5th International Conference on Oncology and Cancer (Cancer Conference 2024), a collaborative effort with generous support and cooperation from dedicated academicians and Editorial Board Members. The conference is scheduled to take place on March 25-26, 2024, in London, UK.

CANCER CONFERENCE 2024 aims to facilitate the exchange of new ideas and technologies among professionals, industrialists, and students within the research domains of Oncology and Cancer. Our premier event features a thoughtfully curated program designed with your interests in mind. We have expanded networking opportunities with colleagues from around the world, introduced focused sessions with cutting-edge presentations, special panel discussions, and dynamic interactions with industry leaders and experts.

We extend a warm invitation to participants from across the globe, encompassing keynote talks, oral presentations, poster sessions, sponsorships, and exhibitions. The conference’s overarching goal is to “Explore Innovative Approaches to the Treatment and Prevention of Oncology and Cancer.”

CANCER CONFERENCE 2024 hosts over 1000 CME Global events annually worldwide, with the support of 1000+ scientific societies. Additionally, we publish 500 open-access journals that feature contributions from over 50,000 eminent personalities and renowned scientists serving as editorial board members. Join us in advancing the discourse on Oncology and Cancer at Cancer Conference 2024.

Who Should Attend?

The CANCER CONFERENCE 2024  is a unique forum that brings together globally recognized academic researchers, public health experts, scientists, doctors, academic researchers, industry specialists, scholars in the fields of Oncology, Hematology, Surgery, Nursing, Radiology, Pediatrics, Physicians, Advocacy, and more. It serves as a platform for discussions on the current state of research and development in these areas.

Target Audience:

Why Should You Attend?

The organizing team has gathered distinguished speakers who will cover the latest advances in the field, ensuring diversity in every aspect. The conference offers exclusive B2B meetings, interactive sessions, panel discussions, keynote sessions, poster presentations, oral presentations, workshops, exhibitions, and more.

Benefits of CANCER CONFERENCE 2024 :

International Speaker Certification

Hard copy of Conference Souvenir, ID card, and certificate sent to your address

All accepted abstracts published in supported journals and Conference Book Proceeding

Opportunity to conduct a workshop with your team members

Networking with Keynote Speakers, OCM, and Eminent personalities for the future course of work

Opportunity to chair a session

Individual Speaker Page created for more visibility of your scientific research

Significant benefits on group registration and much more.

Scope & Importance:

Cancer Conference 2024 and Oncology Conference bring together world-class educators, scientists, and oncologists to discuss diverse strategies for cancer treatment, chemotherapy, and radiology. This event serves as the best platform for oncologists, hematologists, research scholars, and students working in the field to exchange knowledge related to oncology research. The international event aims to comprehend the underlying biological processes that enhance effectiveness, precision, survivability, and quality of life.

 Overview of CANCER CONFERENCE 2024

The exploration of innovative ideas surrounding cancer has sparked extensive research globally. Despite the substantial efforts of numerous researchers and scientists dedicated to cancer research, a definitive solution remains elusive. The Cancer Conference 2024 will address the realms of cancer prevention, diagnosis, and treatment, particularly focusing on organ-related cancers and their innovative approaches. Over two days, the conference will facilitate discussions on strategies related to cancer management, encouraging the exchange of ideas on a global scale. Key topics include the relevance of cancer to other diseases, advances in cancer research and treatment, cancer causes and risk factors, cancer prevention vaccines, medical imaging for cancer, cancer R&D market analysis, cancer screening and diagnosis, oncolytic virus and cancer, cancer nutrition and metabolism, microRNA and cancer, managing cancer care and patient support, radiology and imaging technologies, DNA damage, mutation and cancer, clinical and medical case reports, cancer pathology and genetics, surgical and clinical oncology, cancer nanotechnology, organ-specific cancer, cancer epidemiology, and SNP and cancer.

Who and Why?

The Oncology Research 2024 Conference is a gathering of specialists from various domains to discuss the future of oncology and cancer in today’s world, with a focus on thriving and surviving for better health. The conference welcomes directors, specialists, investigators, post-doctoral fellows, research and diagnostic laboratories, clinical fellows, students, biomedical research companies, healthcare institutions, market research and consulting firms, pharmaceutical companies, and all other interested participants seeking to enhance and update their knowledge in the field.

Conference Highlights 

Sessions and Tracks

Track 1: Fields of Oncology

Oncology, a multidisciplinary field dedicated to the study and treatment of cancer, encompasses various diagnostic methods crucial for patient care. Biopsy and imaging techniques form the backbone of cancer diagnosis, allowing oncologists to identify and understand the nature of tumors. This field often intertwines with hematology oncology, focusing on blood disorders, further broadening its scope. Within oncology, specialists in surgery, radiation, and medical care play pivotal roles, collectively contributing to comprehensive cancer management.

Track 2: Types of Oncology

Oncology delves into the intricate world of tumor studies, discriminating between benign and malignant forms. This distinction is vital in tailoring appropriate treatment strategies. The diverse roles of surgical, radiation, and medical oncologists underscore the comprehensive approach required in cancer care. A nuanced understanding of these specialized roles is crucial for effective collaboration and ensuring optimal patient outcomes.

Track 3: Solid Tumor

Solid tumors, abnormal masses of tissue, can be benign or malignant, presenting unique challenges in cancer diagnosis and treatment. Categorizations such as sarcomas and carcinomas help differentiate these tumors, each requiring a tailored approach. For instance, adrenocortical carcinoma forms in the adrenal glands, highlighting the diversity of solid tumors and the need for specialized expertise in their management.

Track 4: Neurosurgical Oncology

Neurosurgical Oncology addresses disorders affecting the nervous system, a realm where precision is paramount. Procedures such as skull base and laser surgery, spinal neurosurgery, and image-guided surgery are integral in managing cancers impacting the intricate neural structures. The intersection of neurosurgery and oncology underscores the need for a multidisciplinary approach to address the complexity of these cases.

Track 5: Nursing Oncology

Nursing in oncology goes beyond traditional patient care, involving the administration of treatments and a keen assessment of both physical and emotional states. Effective communication and a profound understanding of pathology results are key skills in providing holistic care to cancer patients. Nurses in oncology serve as vital members of the healthcare team, contributing significantly to patient well-being.

Track 6: Medical & Radiation Oncology

Radiation Oncology explores cancer treatment using radiation, employing techniques such as Radiotelegraphy and Brachy-radiotherapy. This specialized field plays a pivotal role in conjunction with medical oncology, combining therapeutic modalities to optimize patient outcomes. The collaboration between medical and radiation oncologists reflects the multifaceted nature of cancer care, where a tailored combination of treatments is often necessary.

Track 7: Neuro Oncology

Central Nervous System malignancies and metastases, along with neurological disorders, fall within the purview of Neuro Oncology. The increased focus on this track is evident in the market growth of CNS therapeutics, reflecting heightened healthcare spending to address the intricate challenges posed by brain and nervous system-related cancers.

Track 8: Brain Tumor

Brain tumors, life-threatening masses with diverse symptoms, necessitate early detection for effective intervention. This track emphasizes the urgency of understanding the nuances of brain tumors, from their varied presentations to the critical importance of timely diagnosis and intervention.

Track 9: Cancer Cell Biology and Genetics

Cancer biology delves into the intricate world of mutations in oncogenes and tumor-suppressor genes, unraveling the complex nature of cancer. The quest to understand the genetic underpinnings of cancer is foundational to developing targeted therapies and advancing personalized treatment approaches.

Track 10: Cancer Biomarkers

Cancer biomarkers, indicative substances that aid in diagnosis and prognosis, hold immense potential for non-invasive testing. The application of these biomarkers in clinical settings is a promising avenue, facilitating early detection and personalized treatment strategies.

Track 11: Cancer Metabolomics

Metabolomics explores diagnostic cancer biomarkers and pathways, providing valuable insights for personalized treatment and ongoing intervention monitoring. This track underscores the importance of understanding the metabolic intricacies of cancer, paving the way for innovative therapeutic approaches.

Track 12: Organ-Defined Cancers

Cancers are categorized based on the affected body part and cell type, influencing critical decisions in treatment planning. This track emphasizes the significance of tailoring therapeutic strategies to the specific organ and cell characteristics, recognizing the diversity of cancers and the need for targeted approaches.

Track 13: Cancer: Psychological Aspects

Cancer patients often grapple with significant psychological distress, and addressing these emotional challenges is a crucial aspect of comprehensive cancer care. This track sheds light on the psychological dimensions of cancer, emphasizing the importance of integrating mental health support into the overall treatment paradigm.

Track 14: Lifestyle Changes for Cancer Care

Promoting healthy lifestyles is integral to positively impacting cancer treatment outcomes and long-term health. This track explores the role of lifestyle modifications in cancer care, emphasizing the potential for improved patient outcomes through holistic well-being.

Track 15: Cancer Epigenetics and Oncogenomics

Genetic alterations contribute significantly to cancer development, and understanding oncogenomics provides valuable insights into clinical outcomes and potential therapeutic interventions. This track delves into the evolving field of cancer epigenetics and oncogenomics, highlighting their role in advancing our understanding of cancer biology.

Track 16: Cancer Screening and Diagnostics

Effective cancer screening tests play a crucial role in early detection, ultimately reducing mortality rates. This track underscores the importance of ongoing advancements in cancer screening technologies, emphasizing their impact on improving patient outcomes through timely diagnosis.

Track 17: Cancer Vaccines

Cancer vaccines represent a promising frontier in preventing or treating cancer by harnessing patients’ immune responses. This track explores the evolving landscape of cancer vaccines, highlighting their potential to revolutionize cancer treatment approaches.

Track 18: Clinical Trials in Cancer Treatment

Clinical trials serve as critical platforms for evaluating new cancer treatments, ensuring their safety and efficacy before widespread use. This track underscores the importance of ongoing research and innovation in cancer treatment through rigorous clinical trial methodologies.

Track 19: Innovations in Cancer Research and Oncology

Continuous drug discovery and development are pivotal in combating cancer, addressing drug resistance, and exploring new therapeutic avenues. This track highlights the dynamic landscape of cancer research, emphasizing the ongoing innovations that contribute to advancements in oncology.

Track 20: Umbilical Cord Stem Cells

Ethical considerations surround the usage of stem cells, and umbilical cord-derived stem cells offer a promising and ethically acceptable source for research and therapies. This track explores the potential of umbilical cord stem cells, recognizing their significance in advancing regenerative medicine without the ethical dilemmas associated with other stem cell sources.

Track 21: Stem Cell and Tissue Homeostasis

Understanding the activity of stem cells is crucial for maintaining tissue homeostasis. This track delves into the intricate balance between stem cells and tissue maintenance, emphasizing the importance of deciphering these processes for potential therapeutic interventions.

Track 22: Stem Cell Aging

Aging impacts stem cell function, influencing tissue renewal and regenerative capabilities. This track explores the dynamic interplay between stem cell biology and aging, shedding light on how age-related changes in stem cells contribute to the broader context of tissue health.

Track 23: Stem Cell Therapy

Stem cells, with their regenerative potential, hold promise for treating various diseases. This track delves into the applications of stem cell therapy, showcasing the evolving landscape of regenerative medicine and its potential to revolutionize treatment approaches across diverse medical conditions.

Track 24: Recent Advances in Stem Cell

Advancements in stem cell research are focused on understanding their differentiation and therapeutic potential. This track highlights recent breakthroughs in the field, showcasing the cutting-edge discoveries that contribute to expanding our knowledge of stem cells and their applications in medicine.

Track 25: Epidermal Stem Cells

Epidermal stem cells play a crucial role in the maintenance and regeneration of skin and hair. This track explores the unique characteristics of epidermal stem cells, emphasizing their significance in dermatology and regenerative medicine.

Track 26: Stem Cell Renewal

Mechanisms governing stem cell renewal play a vital role in tissue maintenance and repair. This track delves into the intricate processes involved in stem cell renewal, shedding light on the fundamental mechanisms that underpin tissue homeostasis.

Track 27: Ethics Considerations in Stem Cell Therapy

Stem cell research raises ethical concerns, necessitating careful consideration in its application. This track explores the ethical considerations surrounding stem cell therapy, emphasizing the importance of ethical frameworks in guiding research and clinical applications.

Track 28: Advances in Developmental Biology and Stem Cells

Developmental biology serves as the foundation for understanding stem cells and their potential applications. This track highlights the symbiotic relationship between developmental biology and stem cell research, showcasing how insights from developmental processes contribute to advancements in regenerative medicine.

Track 29: DNA Damage, Mutation and Cancer

DNA damage, caused by various agents, initiates carcinogenesis. Understanding repair mechanisms and mutations is crucial for cancer research. This track explores the intricate relationship between DNA damage, mutations, and cancer, emphasizing their role in shaping the landscape of cancer biology.

Track 30: MicroRNAs and Cancer

MicroRNAs, regulators of gene expression, play pivotal roles in cancer diagnosis, prognosis, and potential therapeutic interventions. Understanding their functions is essential for advancing cancer research, and this track explores the intricate world of microRNAs and their implications in cancer biology and treatment.

Track 1: Fields of Oncology

Oncology, a multidisciplinary field dedicated to the study and treatment of cancer, encompasses various diagnostic methods crucial for patient care. Biopsy and imaging techniques form the backbone of cancer diagnosis, allowing oncologists to identify and understand the nature of tumors. This field often intertwines with hematology oncology, focusing on blood disorders, further broadening its scope. Within oncology, specialists in surgery, radiation, and medical care play pivotal roles, collectively contributing to comprehensive cancer management.

Track 2: Types of Oncology

Oncology delves into the intricate world of tumor studies, discriminating between benign and malignant forms. This distinction is vital in tailoring appropriate treatment strategies. The diverse roles of surgical, radiation, and medical oncologists underscore the comprehensive approach required in cancer care. A nuanced understanding of these specialized roles is crucial for effective collaboration and ensuring optimal patient outcomes.

Track 3: Solid Tumor

Solid tumors, abnormal masses of tissue, can be benign or malignant, presenting unique challenges in cancer diagnosis and treatment. Categorizations such as sarcomas and carcinomas help differentiate these tumors, each requiring a tailored approach. For instance, adrenocortical carcinoma forms in the adrenal glands, highlighting the diversity of solid tumors and the need for specialized expertise in their management.

Track 4: Neurosurgical Oncology

Neurosurgical Oncology addresses disorders affecting the nervous system, a realm where precision is paramount. Procedures such as skull base and laser surgery, spinal neurosurgery, and image-guided surgery are integral in managing cancers impacting the intricate neural structures. The intersection of neurosurgery and oncology underscores the need for a multidisciplinary approach to address the complexity of these cases.

Track 5: Nursing Oncology

Nursing in oncology goes beyond traditional patient care, involving the administration of treatments and a keen assessment of both physical and emotional states. Effective communication and a profound understanding of pathology results are key skills in providing holistic care to cancer patients. Nurses in oncology serve as vital members of the healthcare team, contributing significantly to patient well-being.

Track 6: Medical & Radiation Oncology

Radiation Oncology explores cancer treatment using radiation, employing techniques such as Radiotelegraphy and Brachy-radiotherapy. This specialized field plays a pivotal role in conjunction with medical oncology, combining therapeutic modalities to optimize patient outcomes. The collaboration between medical and radiation oncologists reflects the multifaceted nature of cancer care, where a tailored combination of treatments is often necessary.

Track 7: Neuro Oncology

Central Nervous System malignancies and metastases, along with neurological disorders, fall within the purview of Neuro Oncology. The increased focus on this track is evident in the market growth of CNS therapeutics, reflecting heightened healthcare spending to address the intricate challenges posed by brain and nervous system-related cancers.

Track 8: Brain Tumor

Brain tumors, life-threatening masses with diverse symptoms, necessitate early detection for effective intervention. This track emphasizes the urgency of understanding the nuances of brain tumors, from their varied presentations to the critical importance of timely diagnosis and intervention.

Track 9: Cancer Cell Biology and Genetics

Cancer biology delves into the intricate world of mutations in oncogenes and tumor-suppressor genes, unraveling the complex nature of cancer. The quest to understand the genetic underpinnings of cancer is foundational to developing targeted therapies and advancing personalized treatment approaches.

Track 10: Cancer Biomarkers

Cancer biomarkers, indicative substances that aid in diagnosis and prognosis, hold immense potential for non-invasive testing. The application of these biomarkers in clinical settings is a promising avenue, facilitating early detection and personalized treatment strategies.

Track 11: Cancer Metabolomics

Metabolomics explores diagnostic cancer biomarkers and pathways, providing valuable insights for personalized treatment and ongoing intervention monitoring. This track underscores the importance of understanding the metabolic intricacies of cancer, paving the way for innovative therapeutic approaches.

Track 12: Organ-Defined Cancers

Cancers are categorized based on the affected body part and cell type, influencing critical decisions in treatment planning. This track emphasizes the significance of tailoring therapeutic strategies to the specific organ and cell characteristics, recognizing the diversity of cancers and the need for targeted approaches.

Track 13: Cancer: Psychological Aspects

Cancer patients often grapple with significant psychological distress, and addressing these emotional challenges is a crucial aspect of comprehensive cancer care. This track sheds light on the psychological dimensions of cancer, emphasizing the importance of integrating mental health support into the overall treatment paradigm.

Track 14: Lifestyle Changes for Cancer Care

Promoting healthy lifestyles is integral to positively impacting cancer treatment outcomes and long-term health. This track explores the role of lifestyle modifications in cancer care, emphasizing the potential for improved patient outcomes through holistic well-being.

Track 15: Cancer Epigenetics and Oncogenomics

Genetic alterations contribute significantly to cancer development, and understanding oncogenomics provides valuable insights into clinical outcomes and potential therapeutic interventions. This track delves into the evolving field of cancer epigenetics and oncogenomics, highlighting their role in advancing our understanding of cancer biology.

Track 16: Cancer Screening and Diagnostics

Effective cancer screening tests play a crucial role in early detection, ultimately reducing mortality rates. This track underscores the importance of ongoing advancements in cancer screening technologies, emphasizing their impact on improving patient outcomes through timely diagnosis.

Track 17: Cancer Vaccines

Cancer vaccines represent a promising frontier in preventing or treating cancer by harnessing patients’ immune responses. This track explores the evolving landscape of cancer vaccines, highlighting their potential to revolutionize cancer treatment approaches.

Track 18: Clinical Trials in Cancer Treatment

Clinical trials serve as critical platforms for evaluating new cancer treatments, ensuring their safety and efficacy before widespread use. This track underscores the importance of ongoing research and innovation in cancer treatment through rigorous clinical trial methodologies.

Track 19: Innovations in Cancer Research and Oncology

Continuous drug discovery and development are pivotal in combating cancer, addressing drug resistance, and exploring new therapeutic avenues. This track highlights the dynamic landscape of cancer research, emphasizing the ongoing innovations that contribute to advancements in oncology.

Track 20: Umbilical Cord Stem Cells

Ethical considerations surround the usage of stem cells, and umbilical cord-derived stem cells offer a promising and ethically acceptable source for research and therapies. This track explores the potential of umbilical cord stem cells, recognizing their significance in advancing regenerative medicine without the ethical dilemmas associated with other stem cell sources.

Track 21: Stem Cell and Tissue Homeostasis

Understanding the activity of stem cells is crucial for maintaining tissue homeostasis. This track delves into the intricate balance between stem cells and tissue maintenance, emphasizing the importance of deciphering these processes for potential therapeutic interventions.

Track 22: Stem Cell Aging

Aging impacts stem cell function, influencing tissue renewal and regenerative capabilities. This track explores the dynamic interplay between stem cell biology and aging, shedding light on how age-related changes in stem cells contribute to the broader context of tissue health.

Track 23: Stem Cell Therapy

Stem cells, with their regenerative potential, hold promise for treating various diseases. This track delves into the applications of stem cell therapy, showcasing the evolving landscape of regenerative medicine and its potential to revolutionize treatment approaches across diverse medical conditions.

Track 24: Recent Advances in Stem Cell

Advancements in stem cell research are focused on understanding their differentiation and therapeutic potential. This track highlights recent breakthroughs in the field, showcasing the cutting-edge discoveries that contribute to expanding our knowledge of stem cells and their applications in medicine.

Track 25: Epidermal Stem Cells

Epidermal stem cells play a crucial role in the maintenance and regeneration of skin and hair. This track explores the unique characteristics of epidermal stem cells, emphasizing their significance in dermatology and regenerative medicine.

Track 26: Stem Cell Renewal

Mechanisms governing stem cell renewal play a vital role in tissue maintenance and repair. This track delves into the intricate processes involved in stem cell renewal, shedding light on the fundamental mechanisms that underpin tissue homeostasis.

Track 27: Ethics Considerations in Stem Cell Therapy

Stem cell research raises ethical concerns, necessitating careful consideration in its application. This track explores the ethical considerations surrounding stem cell therapy, emphasizing the importance of ethical frameworks in guiding research and clinical applications.

Track 28: Advances in Developmental Biology and Stem Cells

Developmental biology serves as the foundation for understanding stem cells and their potential applications. This track highlights the symbiotic relationship between developmental biology and stem cell research, showcasing how insights from developmental processes contribute to advancements in regenerative medicine.

Track 29: DNA Damage, Mutation and Cancer

DNA damage, caused by various agents, initiates carcinogenesis. Understanding repair mechanisms and mutations is crucial for cancer research. This track explores the intricate relationship between DNA damage, mutations, and cancer, emphasizing their role in shaping the landscape of cancer biology.

Track 30: MicroRNAs and Cancer

MicroRNAs, regulators of gene expression, play pivotal roles in cancer diagnosis, prognosis, and potential therapeutic interventions. Understanding their functions is essential for advancing cancer research, and this track explores the intricate world of microRNAs and their implications in cancer biology and treatment.

Market Analysis

Cancer, characterized by uncontrolled cell growth, claims a staggering one in seven lives globally. Surpassing AIDS, tuberculosis, and malaria, it ranks as a primary cause of death. In high-income nations, cancer stands second after cardiovascular diseases, while in low- and middle-income countries, it claims the third spot.

Focusing on cancer diagnostics, the market is poised for substantial growth, projected to surge from $9.2 billion (2023) to a formidable $25.7 billion. The surge is fueled by rising oncologic cases, continuous diagnostic tech innovations, and a growing need for efficient screening tools worldwide. Government initiatives and heightened awareness further bolster this expansion.

The cancer diagnostics market divides into instrument-based and platform-based technologies. Instruments like biopsy, mammography, PET, ultrasound, MRI, and CT dominate, while platforms include in situ hybridization, flow cytometry, next-generation sequencing, and microarrays.

Breast cancer leads diagnostic applications, reflecting a significant market share. With an aging population and escalating cancer cases, substantial opportunities for diagnostic advancements emerge.

Geographically, North America claims the lion’s share, trailed by Europe and Asia. This market’s trajectory signals a critical intersection of technological advancement, increasing cancer prevalence, and global collaborative efforts, underscoring the urgency of effective cancer diagnostics on a broad scale.

– Quick Contact –